Hemoglobin A1c in diabetes: panacea or pointless?

PubWeight™: 0.88‹?›

🔗 View Article (PMC 3526051)

Published in Diabetes on January 01, 2013

Authors

David B Sacks1

Author Affiliations

1: Department of Laboratory Medicine, National Institutes of Health, Bethesda, Maryland, USA. sacksdb@mail.nih.gov

Articles cited by this

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (1998) 95.79

10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med (2008) 35.49

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 27.77

Standards of medical care in diabetes--2010. Diabetes Care (2010) 24.28

New hemoglobin in normal adult blood. Science (1955) 4.23

IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem (2004) 4.02

Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem (2001) 3.63

Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood (2008) 3.12

Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group. Clin Chem Lab Med (2007) 2.46

Biological variation of glycohemoglobin. Clin Chem (2002) 2.38

A1C versus glucose testing: a comparison. Diabetes Care (2011) 2.37

Distribution of HbA(1c) levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Survey. Diabetes Care (2002) 2.24

Racial differences in glycemic markers: a cross-sectional analysis of community-based data. Ann Intern Med (2011) 2.19

Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care. Clin Chem (2010) 1.95

Fructosamine: structure, analysis, and clinical usefulness. Clin Chem (1987) 1.83

Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia (1990) 1.79

An abnormal hemoglobin in red cells of diabetics. Clin Chim Acta (1968) 1.76

Association between iron deficiency and A1C Levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care (2010) 1.75

The IFCC Reference Measurement System for HbA1c: a 6-year progress report. Clin Chem (2008) 1.70

Clinical impact of glycated albumin as another glycemic control marker. Endocr J (2010) 1.53

Standards of medical care for patients with diabetes mellitus. Diabetes Care (1989) 1.50

Effects of iron deficiency anemia on hemoglobin A1c in type 1 diabetes mellitus. Pediatr Int (1999) 1.35

Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. Nephrology (Carlton) (2012) 0.96

Haemoglobin A1c analysis in the management of patients with diabetes: from chaos to harmony. J Clin Pathol (2008) 0.95

Presidents' statement on WHO recommendation on HbA1c for diabetes diagnosis. Diabetes Res Clin Pract (2011) 0.83